Achromatopsia NGS 6 ATF6, CNGA3, CNGB3, GNAT2, PDE6C, PDE6H ARMS2, CFH Sequencing PAX6 MLPA 1 PAX6
|
|
- Hubert McBride
- 5 years ago
- Views:
Transcription
1 Asper Ophthalmics Achromatopsia 6 ATF6, CNGA3, CNGB3, GNAT2, PDE6C, PDE6H 05 Age-related Macular Degeneration 5 ABCA4, ARMS2, C2, C3, C9, CFB, CFH, CFI, 995* CST3, CX3CR, ERCC6, FBLN5, HMCN, HTRA, RAX2 2/3 ARMS2, CFH 87 Aniridia PAX6 MLPA PAX6 773 Anophthalmia/ Microphthalmia/ Coloboma/Anterior Segment Dysgenesis 35 ABCB6, ALDHA3, ASPH, BCOR, B3GLCT, BMP4, CHD7, COL4A, CYPB, EYA, FOXC, FOXE3, GDF3, GDF6, HCCS, HESX, HMGB3, LTBP2, MAB2L2, MFRP, OTX2, PAX6, PITX2, PRSS56, RARB, RAX, SIX6, SLC38A8, SMOC, SOX2, STRA6, TENM3, VAX, VSX, VSX2 34 Autosomal Dominant Retinitis Pigmentosa Autosomal Recessive Retinitis Pigmentosa by by CA4, CRX, FSCN2, IMPDH, KLHL7, NR2E3, NRL, PRPF3, PRPF8, PRPF3, PRPH2, RHO, ROM, RP, RP9, TOPORS AIPL, BEST, CA4, CRX, FSCN2, GUCAB, IMPDH, KLHL7, NR2E3, NRL, PRKCG, PRPF3, PRPF6, PRPF8, PRPF3, PRPH2, RDH2, RGR, RHO, ROM, RP, RP9, RPE65, SEMA4A, SNRNP200, TOPORS MLPA 4 IMPDH, PRPF3, RHO, RP ABCA4, AIPL, CERKL, CLRN, CNGA, CNGA3, CNGB, CNGB3, CRB, EYS, GRK, IMPG2, LRAT, MERTK, NR2E3, PDE6A, PDE6B, PROM, RBP3, RDH2, RGR, RHO, RLBP, RP, RPE65, SAG, TULP, USH2A ABCA4, AIPL, ARL6, BEST, C2orf7, C8ORF37, CA4, CERKL, CLRN, CNGA, CNGB, CRB, CRX, DHDDS, EYS, FAM6A, FLVCR, FSCN2, GUCAB, IDH3B, IMPDH, IMPG2, LRAT, MAK, MERTK, NR2E3, NRL, PDE6A, PDE6B, PDE6G, PRCD, PROM, PRPF3, PRPF6, PRPF8, PRPF3, PRPH2, RBP3, RDH2, RGR, RHO, RLBP, ROM, RP, RP2, RP9, RPE65, RPGR (ORF5 excluded), SAG, SEMA4A, SPATA7, TOPORS, TTC8, TULP, USH2A, ZNF53 MLPA 7 EYS, IMPDH, PRPF3, RHO, RP, RP2, RPGR RPE65 55 Vaksali 7A, 5040 Tartu, Estonia
2 Disease/Condition name Method No No of of genes Bardet-Biedl Syndrome, McKusick-Kaufman Syndrome, Borjeson- Forssman-Lehmann Syndrome, Alstrom Syndrome, Albright Hereditary Osteodystrophy by 6 Asper Ophthalmics ALMS (excluding exon 8), ARL6, BBS, BBS2, BBS4, BBS5, BBS7, BBS9, BBS0, BBS2, GNAS, MKKS, MKS, PHF6, TRIM32, TTC8 22 ALMS, ARL6, BBS, BBS2, BBS4, BBS5, BBS7, BBS9, BBS0, BBS2, CCDC28B, CEP290, GNAS, 34 LZTFL, MKS, MKKS, PHF6, SDCCAG8, TMEM67, TRIM32, TTC8, WDPCP 450 Cataract 44 AGK, BCOR, BFSP, BFSP2, CHMP4B, CRYAA, CRYAB, CRYBA, CRYBA4, CRYBB, CRYBB2, CRYBB3, CRYGB, CRYGC, CRYGD, CRYGS, CTDP, EPHA2, EYA, FTL, FYCO, GALK, GCNT2, GJA, GJA3, GJA8, HSF4, LIM2, LSS, MAF, MIP, NHS, P3H2, PAX6, PITX3, PXDN, SIPAL3, SIL, SIX6, SLC6A2, TDRD7, UNC45B, VIM, VSX2 34 Choroideremia CHM 773 MLPA CHM Cone-Rod Dystrophy 32 ABCA4, ADAM9, AIPL, BEST, CABP4, CAC- NAF, CACNA2D4, CDHR, CERKL, CNGB3, CNNM4, C8ORF37, CRX, GNAT2, GUCAA, GUCY2D, KCNV2, PDE6C, PDE6H, PITPNM3, PROM, PRPH2, RAB28, RAX2, RDH5, RGS9, RGS9BP, RIMS, RPGR (ORF5 excluded), RPGRIP, SEMA4A, UNC9 34 Congenital Stationary Night Blindness 3 CABP4, CACNAF, CHM, GNAT, GRK, GRM6, NYX, PDE6B, RDH5, RHO, SAG, SLC24A, TRPM 05 Corneal Dystrophy 20 CHST6, COL5A, COL7A, COL8A2, CYP4V2, DCN, GSN, KRT3, KRT2, LOXHD, PIKFYVE, PRDM5, SLC4A, SOD, ZEB, ZNF469, TAC- STD2, TGFBI, UBIAD, VSX Glaucoma 9 ACVR, ASB0, BEST, CANT, COL8A, CYPB, FOXC, LMXB, LOXL, LTBP2, MYOC, NTF4, OPTN, PAX6, PITX2, PITX3, SBF2, SLC4A4, WDR Leber Congenital Amaurosis by 5 20 AIPL, CEP290, CRB, CRX, GUCY2D, IQCB, LCA5, LRAT, MERTK, RD3, RDH2, RPE65, RPGRIP, SPATA7, TULP AIPL, CABP4, CEP290 (intronic position c a>g included), CRB, CRX, GDF6, GUCY2D, IMPDH, IQCB, KCNJ3, LCA5, LRAT, NMNAT, OTX2, RD3, RDH2, RPE65, RPGRIP, SPATA7, TULP MLPA 8 AIPL, CEP290, CRB, CRX, GUCY2D, RDH2, RPE65, RPGRIP 806 Vaksali 7A, 5040 Tartu, Estonia
3 Asper Ophthalmics Leber Hereditary Optic Neuropathy RFLP 3/3 MT-ND, MT-ND4, MT-ND6 76 Norrie Disease NDP 262 Oculocutaneous Albinism, Ocular Albinism, Hermansky-Pudlak Syndrome, Chediak-Higashi Syndrome 7 AP3B, BLOCS3, BLOCS6, DTNBP, GPR43, HPS, HPS3, HPS4, HPS5, HPS6, LRMDA, LYST, OCA2, SLC24A5, SLC45A2, TYR, TYRP MLPA 3 GPR43, OCA2, TYR Optic Atrophy by OPA OPA, OPA3, TMEM26A 030 MLPA OPA Papillorenal Syndrome PAX2 525 Retinoblastoma MLPA RB RB 960 Stargardt Disease ABCA ABCA4, CNGB3, ELOVL4, PROM 030 MLPA ABCA4 Usher Syndrome by 9 ADGRV (GPR98), CDH23, CLRN, MYO7A, PCDH5, USH2A, USHC, USHG, WHRN (DFNB3) ABHD2, ADGRV (GPR98), CDH23, CIB2, CLRN, COL4A6, DSPP (excluding exon 5), GIPC3, HARS, KARS, LHFPL5, LOXHD, MYO7A, PCDH5, PDZD7, TNC, USH2A, USHC, USHG, WHRN (DFNB3) 05 MLPA USH2A MLPA PCDH5 Vitelliform Macular Dystrophy BEST MLPA 2 Vitreoretinopathy 9 BEST, PRPH2 BEST, PRPH2 BEST, CAPN5, COL2A, COL9A, COL9A2, COL9A3, COLA, COLA2, COL8A, FZD4, KCNJ3, KIF, LRP5, NDP, NR2E3, RS, TSPAN2, VCAN, ZNF Vaksali 7A, 5040 Tartu, Estonia
4 Asper Ophthalmics X-Linked Retinitis Pigmentosa by,, 2 3 MLPA 2 RP2, RPGR RP2, RPGR (ORF5 included) RPGR (ORF5 region only) OFD, RP2, RPGR (ORF5 included) X-Linked Retinoschisis RS 395 Eye Diseases genes associated with different eye diseases 567 Whole Exome (WES) Whole Genome (WGS) * Clinical interpretation is not available Service includes DNA extraction Genotyping Bioinformatic analysis of detected variants Detected variants available in Excel format (on request) Validation of phenotype/diagnosis associated known or possibly pathogenic variants Clinical and biological interpretation Results delivery by registered mail (on request) TAT 2-9 weeks, excl. WES and WGS 5 weeks Online ordering, specimen requirements and shipping instructions are available at Vaksali 7A, 5040 Tartu, Estonia
5 Ashkenazi Jewish Diseases Carriership Cystic Fibrosis Folate-Dependent Neural Tube Defects by TruSightTM Inherited Disease 3 33 Asper Reprogenetics ABCC8, AGL, ASPA, BBS2, BCKDHB, BLM, BRCA, BRCA2, CFTR, CLRN, DHDDS, DLD, FAM6A, F, FANCC, GBA, GJB2, G6PC, HEXA, IKBKAP, LCA5, LDLR, MAK, MCOLN, MEFV, NEB, PCDH5, SERPINA, SMPD, TMEM26, TORA ABCC8, AGL, ASPA, BCKHDB, BLM, BRCA, BRCA2, CFTR, CLRN, CYP2A2, DLD, F, FANCC, FKTN, GBA, GJB2, G6PC, HEXA, IKBKAP, LCA5, LDLR, LRRK2, MCOLN, MEFV, MSH2, MSH6, NEB, PCDH5, SERPINA, SMN, SMPD, TMEM26, TORA genes associated with inherited diseases Fragile X Syndrome Repeat FMR 262 Expansion/ Fragment Length Analysis CFTR MLPA CFTR mutation analysis Male Factor Infertility 9 CFTR, DDX25, DNAH5, DNAH, DNAI, ESR2, 624 FSHB, GNRHR, INSL3, NLRP4, PRDM9, PRM, PRM2, PRM3, RBMXL2, RXFP2, TEKT2, USP26, by, PCR UTP4C 47XXY AZF deletions by 9 MTHFR CFTR, DDX25, DNAH5, DNAH, DNAI, ESR2, FSHB, GNRHR, INSL3, NLRP4, PRDM9, PRM, PRM2, PRM3, RBMXL2, RXFP2, TEKT2, USP26, UTP4C Maternal Cell Contamination PCR 47XXY N/A 87 PCR 3/8 (+9 for AZF deletions 87 extended analysis) Fragment Analysis NA/6 87 Whole Exome (WES) Whole Genome (WGS) Vaksali 7A, 5040 Tartu, Estonia
6 Asper Reprogenetics * Clinical interpretation is not available Service includes DNA extraction Genotyping Bioinformatic analysis of detected variants Detected variants available in Excel format (on request) Validation of phenotype/diagnosis associated known or possibly pathogenic variants Clinical and biological interpretation Results delivery by registered mail (on request) TAT 2-9 weeks, excl. WES and WGS 5 weeks Online ordering, specimen requirements and shipping instructions are available at Vaksali 7A, 5040 Tartu, Estonia
7 Asper Oncogenetics Breast and Ovarian/ Endometrial Cancer 2 23 BRCA, BRCA2 MLPA 2 BRCA, BRCA MLPA 2 BRCA, BRCA2 803 ATM, BARD, BRCA, BRCA2, BRIP, CDH, CHEK2, MEN, MLH, MREA, MSH2, MSH6, MUTYH, NBN, PALB2, PTCH, PTEN, RAD50, RAD5C, RAD5D, STK, TP53, XRCC Cancer Predisposition 02 AIP, ALK, APC, ATM, BAP, BARD, BLM, BMPRA, BRCA, BRCA2, BRIP, BUBB, CDC73, CDH, CDK4, CDKNC, CDKN2A, CEBPA, CEP57, CHEK2, CYLD, DDB2, DICER, DIS3L2, EGFR, EPCAM, ERCC2, ERCC3, ERCC4, ERCC5, EXT, EXT2, EZH2, FANCA, FANCB, FANCC, FANCD2 (excluding exon 5, 6), FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, FH, FLCN, GATA2, GPC3, HNFA, HOXB3, HRAS, KIT, MAX, MEN, MET, MITF, MLH, MREA, MSH2, MSH6, MUTYH, NBN, NF, NF2, NSD, NTHL, PALB2, PHOX2B, POLD, PRF, PRKARA, PRSS, PTCH, PTEN, RAD50, RAD5C, RAD5D, RB, RECQL4, RET, RHBDF2, RUNX, SBDS, SDHA, SDHAF2, SDHB, SDHC, SDHD, SLX4, SMAD4, SMARCB, STK, SUFU, TMEM27, TP53, TSC, TSC2, VHL, WRN, WT, XPA, XPC, XRCC2 05 MLPA RB MLPA WT MLPA 2 NF, NF2 070 Familial Adenomatous Polyposis APC 773 MLPA APC Fanconi Anemia Lynch Syndrome Melanoma 7 BRCA2, BRIP, ERCC4, FANCA, FANCB, 05 FANCC, FANCD2 (excluding exons 5, 6), FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, PALB2, RAD5C, SLX4, XRCC2 MLPA 4 FANCA, FANCB, FANCD2, PALB2 070 MLH MSH2 MSH6 3 MLH, MSH2, MSH6 030 MLPA 2 MLH, MSH2 MLPA MSH6 3 CDK4, CDKN2A, MITF 070 MLPA 4 CDK4, CDKN2A, CDKN2B, MITF Vaksali 7A, 5040 Tartu, Estonia
8 Asper Oncogenetics Microsatellite instability MUTYH-associated Polyposis Nijmegen Breakage Syndrome Fragment Analysis MLPA NA/6 / MUTYH MUTYH RFLP /2 MUTYH 70 NBN NBN Polyposis Syndromes 6 MLPA 3 MLPA APC, BMPRA, MUTYH, PTEN, SMAD4, STK BMPRA, PTEN, SMAD4 STK 030 Thyroid Cancer 0 APC, CDC73, DICER, MEN, PRKARA, PTEN, 05 SDHB, SDHD, RET, TP53 MLPA 3 SDHB, SDHC, SDHD MLPA MEN Whole Exome (WES) Whole Genome (WGS) Service includes DNA extraction Genotyping Bioinformatic analysis of detected variants Detected variants available in Excel format (on request) Validation of phenotype/diagnosis associated known or possibly pathogenic variants Clinical and biological interpretation Results delivery by registered mail (on request) TAT 2-9 weeks, excl. WES and WGS 5 weeks Online ordering, specimen requirements and shipping instructions are available at Vaksali 7A, 5040 Tartu, Estonia
9 Asper Cardiogenetics Apolipoprotein C-II Deficiency APOC2 267 Arrhythmia 40 ABCC9, AKAP9, ANK2, CACNAC, CACNA2D, CACNB2, CASQ2, CAV3, DES, DSC2, DSG2, DSP, GJA5, GPDL, HCN4, JUP, KCNA5, KCND3, 338 KCNE, KCNE2, KCNE3, KCNE5 (KCNEL), KCNH2, KCNJ2, KCNJ8, KCNQ, LMNA, NKX2-5, NPPA, PKP2, PLN, RYR2, SCNB, SCN2B, SCN3B, SCN4B, SCN5A, SNTA, TGFB3, TMEM43 Arrhythmogenic Right Ventricular Dysplasia/ Cardiomyopathy 4 CTNNA3, DES, DSG2, DSC2, DSP, JUP, LDB3, 070 LMNA, PKP2, PLN, RYR2, TGFB3, TMEM43, TTN MLPA 2 DSP, PKP2 Brugada Syndrome 5 CACNAC, CACNA2D, CACNB2, GPDL, HCN4, KCND3, KCNE3, KCNEL, KCNJ8, RANGRF, SCN5A, SCNB, SCN2B, SCN3B, TRPM4 34 MLPA SCN5A Catecholaminergic Polymorphic Ventricular Tachycardia 6 ANK2, CALM, CASQ2, KCNJ2, RYR2, TRDN 070 Dilated Cardiomyopathy 44 ABCC9, ACTC, ACTN2, ANKRD, BAG3, CSRP3, CRYAB, DES, DMD, DNAJC9, DOLK, DSC2, DSG2, DSP, EMD, EYA4, GATAD, JUP, LAMA4, LAMP2, LDB3, LMNA, MYBPC3, MYH6, MYH7, MYPN, NEXN, PKP2, PLN, RAF, RBM20, SCN5A, SGCD, TAZ, TBX20, TCAP, TMPO, TNNC, TNNI3, TNNT2, TPM, TTN, TTR, VCL 070 MLPA 2 BAG3, TNNT2 Familial Hypercholesterolemia Familial Lipoprotein Lipase Deficiency Familial Thoracic Aortic Aneurysm and Dissection and Related Syndromes 4 APOB, LDLR, LDLRAP, PCSK9 030 MLPA LDLR LPL 267 MLPA LPL 2 ACTA2, COL3A, COL5A, FBN, MYH, MYLK, 288 SLC2A0, SMAD3, TGFB2, TGFBR, TGFBR2, TGFBR3 MLPA 3 FBN, TGFBR, TGFBR2 806 Hyperlipoproteinemia, type 3 Hyperlipoproteinemia, type 5 /2 APOE 87 APOEA5 267 Hyperlipidemia 6 APOA5, APOC2, GPD, GPIHBP, LMF, LPL 070 Vaksali 7A, 5040 Tartu, Estonia
10 Hypertrophic Cardiomyopathy Lecithin Cholesterol Acyltransferase Deficiency Pulmonary Arterial Hypertension Statin-Induced Myopathy Asper Cardiogenetics Noonan Syndrome 3 BRAF, CBL, HRAS, KAT6B, KRAS, MAP2K, 05 MAP2K2, NRAS, PTPN, RAF, SHOC2, SOS, SPRED / SLCOB 87 2 ACVRL, BMPR2, BMPRB, CAV, EIF2AK4, 338 ENG, FOXF, GDF2, KCNA5, KCNK3, SMAD4, SMAD9 MLPA 2 ACVRL, BMPR2 Short QT Syndrome 5 CACNAC, CACNB2, KCNH2, KCNJ2, KCNQ 070 Tangier Disease ABCA 070 Thrombophilia RFLP 3/4 F2, F5, MTHFR 87 Whole Exome (WES) 28 ACTC, ACTN2, CALR3, CAV3, CSRP3, GLA, JPH2, LAMP2, LDB3, MYBPC3, MYH6, MYH7, MYL2, MYL3, MYLK2, MYOZ2, MYPN, NEXN, PLN, PRKAG2, SLC25A4, TCAP, TNNC, TNNI3, TNNT2, TPM, TTR, VCL 34 MLPA 3 MYBPC3, MYH7, TNNT2 806 LCAT 267 Long QT Syndrome 4 AKAP9, ANK2, CACNAC, CALM, CAV3, 05 KCNE, KCNE2, KCNH2, KCNJ2, KCNJ5, KCNQ, SCN5A, SCN4B, SNTA MLPA 2 KCNH2, KCNQ Whole Genome (WGS) Service includes DNA extraction Genotyping Bioinformatic analysis of detected variants Detected variants available in Excel format (on request) Validation of phenotype/diagnosis associated known or possibly pathogenic variants Clinical and biological interpretation Results delivery by registered mail (on request) TAT 2-9 weeks, excl. WES and WGS 5 weeks Online ordering, specimen requirements and shipping instructions are available at Vaksali 7A, 5040 Tartu, Estonia
11 Alzheimer Disease Amyotrophic Lateral Sclerosis Autism Spectrum Disorders Charcot-Marie-Tooth Disease Congenital Myopathy and Distal Myopathy Asper Neurogenetics /2 APOE ALS2, ANG, CHCHD0, CHMP2B, ERBB4, FIG4, FUS, MATR3, OPTN, PFN, SETX, SIGMAR, SOD, SPART, SPG, SQSTM, TARDBP, TBK, TUBA4A, UBQLN2, VAPB, VCP ADNP, ADSL, ANKRD, ARX, AVPRA, BRAF, CACNAC, CDKL5, CHD2, CHD7, CNTNAP2, CREBBP, DHCR7, EHMT, EN2, FOXG, FOXP, 338 FOXP2, GABRB3, HDAC8, HOXA, HPRT, MAGEL2, MECP2, MED2, MID, NHS, NIPBL, NLGN3, NLGN4X, NRXN, NSD, NTNG, OXTR, PCDH9, PDE8B, POGZ, PTCHD, PTEN, PTPN, PQBP, RAD2, RAI, RELN, RPL0, SCNA, SCN2A, SETD2, SHANK2, SHANK3, SLC6A4, SLC6A8, SLC9A9, SMC3, SMCA, TBLXR, TCF4, TSC, TSC2, UBE3A, VPS3B, ZEB2 67 AARS, AIFM, ARSA, BSCL2, C2orf65, COX6A, 34 DCTN, DHTKD, DNAJB2, DNM2, DYNCH, EGR2, FGD4, FIG4, GAN, GARS, GDAP, GJB, GNB4, HARS, HINT, HK, HSPB, HSPB3, HSPB8, IGHMBP2, INF2, KARS, KIFA, KIF5A, KIFB, LITAF, LMNA, LRSAM, MARS, MED25, MFN2, MORC2, MPZ, MTMR2, NAGLU, NDRG, NGF, PDK3, PLEKHG5, PMP22, POLG, PRPS, PRX, RAB7A, REEP, SBF, SBF2, SCN9A, SETX, SH3TC2, SLC5A7, SPTLC, SPTLC2, SURF, TFG, TRIM2, TRPV4, TYMP, VCP, WNK, YARS MLPA 2 KIFB, PMP22 MLPA GJB MLPA 2 MFN2, MPZ MLPA 5 GARS, HSPB, HSBP8, RAB7A, SPTLC MLPA 7 EGR2, GDAP, MTMR2, NEFL, SBF2, SH3TC2, PRX 42 ACTA, ANO5, BAG3, BIN, CAV3, CCDC78, CFL2, 338 CNTN, COL6A, COL6A3, COL2A, CRYAB, DES, DNAJB6, DNM2, DYSF, FHL, FLNC, GNE, KLHL40, KLHL4, LDB3, LMOD3, MATR3, MEGF0, MICU, MTM, MTMR4, MYF6, MYH7, MYOT, NEB, RYR, SELENON, STAC3, SQSTM, TIA, TNNT, TPM2, TPM3, TTN, VCP MLPA 2 MTM, MTMR Cornelia de Lange Syndrome Craniosynostosis 9 AFF4, ANKRD, HDAC8, KMT2A, NIPBL, RAD2, 030 SMC3, SMCA, TAF6 MLPA NIPBL, 7 AFF4, ANKRD, HDAC8, KMT2A, NIPBL, RAD2, 05 SMC3, SMCA, TAF6 MLPA TWIST Vaksali 7A, 5040 Tartu, Estonia
12 Asper Neurogenetics Dystonia 39 ACTB, ADCY5, ANO3, ARSA, ATM, ATPA3, 34 ATP7B, CACNAB, CIZ, COL6A3, DRD2, GCDH, GCH, GNAL, GNAO, HPCA, KCNMA, KCTD7, PANK2, PLA2G6, PNKD, PRKN, PRKRA, PRRT2, RELN, SGCE, SLC2A, SLC6A3, SLC25A, SLC30A0, SLC39A4, SPR, TAF, TBCE, TH, THAP, TIMM8A, TORA, TUBB4A MLPA 7 ATPA3, GCH, PRKRA, SGCE, TH, THAP, TORA 70 Fragile X Syndrome Epilepsy 27 AARS, ADAR, ADSL, ALDH7A, ALG3, ALG3, ARHGEF9, ARX, ATPA2, ATPA3, ATP6AP2, ATRX, BRAT, CACNAA, CACNAD, CACNAH, CACNB4, CASK, CDKL5, CERS, CHD2, CHRNA2, CHRNA4, CHRNB2, CLCN2, CPA6, CSTB, DEPDC5, DNM, DOCK7, EEFA2, EFHC, EPM2A, FGF2, 546 FLNA, FOXG, GABRA, GABRB3, GABRD, GABRG2, GAMT, GATM, GNAO, GOSR2, GPHN, GRIN, GRIN2A, GRIN2B, HCN, HUWE, ITPA, IQSEC2, KCNA, KCNA2, KCNB, KCNC, KCNMA, KCNQ2, KCNQ3, KCNT, KCTD7, KIAA2022, KIFA, KIF5C, LGI, MBD5, MCCC, MECP2, MEF2C, MOCS, MOCS2, MTOR, NECAP, NHLRC, NRXN, PCDH9, PIK3R2, PIGA, PIGO, PIGT, PLCB, PNKP, PNPO, POLG, PRICKLE, PRRT2, PURA, RELN, ROGDI, SCARB2, SCNA, SCNB, SCN2A, SCN8A, SERPINI, SIK, SLC2A5, SLC3A5, SLC25A22, SLC2A, SLC35A2, SLC35A3, SLC6A, SLC6A8, SLC9A6, SMARCA2, SNIP, SPATA5, SPTAN, SRPX2, ST3GAL3, ST3GAL5, STXB, STXBP, SYN, SYNGAP, SYP, SZT2, TBCD24, TCF4, TSC, TSC2, TUBB3, UBE3A, WDR45, WWOX, ZDHHC9 MLPA CHRNA4, CHRNB2, EPM2A, KCNQ, KCNQ3, 334 NHLRC, PCDH9, SCNA, SLC2A, STXBP, WWOX Repeat Expansion/ Fragment FMR 262 Length Analysis Frontotemporal Dementia Hereditary Spastic Paraplegia 5 CHMP2B, GRN, MAPT, TARDBP, 05 PSEN MLPA 3 CRHR, GRN, MAPT 34 ATL, AP4B, AP4E, AP4M, AP4S, AP5Z, B4GALNT, BSCL2, CYP7B, CYP2U, DDHD2, ERLIN2, FA2H, GBA2, GJC2, HSPD, KIFA, KIF5A, LCAM, NIPA, PLP, PNPLA6, REEP, RTN2, SLC6A2, SPAST, SPG7, SPG, SPG20, SPG2, TECPR2, VPS37A, WASHC5, ZFYVE26 34 / MT-ATP6 87 MLPA 5 ATL, NIPA, SPAST, SPG7, REEP 806 Vaksali 7A, 5040 Tartu, Estonia
13 Asper Neurogenetics Joubert Syndrome 29 AHI, ARL3B, B9D, B9D2, C5orf42, CC2D2A, CEP290, CEP4, CEP04, CSPP, INPP5E, KIF7, KIAA0556, KIAA0586, MKS, NPHP, OFD, PDE6D, RPGRIPL, TCTN, TCTN2, TCTN3, TMEM38, TMEM26, TMEM23, TMEM67, TMEM237, TTC2B, ZNF423 Leukodystrophy and Leukoencephalopathy, 40 ABCD, ADAR, AIMP, ARSA, ASPA, CLCN2, CSFR, DARS2, EARS2, EIF2B, EIF2B2, EIF2B3, EIF2B4, EIF2B5, FAM26A, FOLR, GALC, GFAP, GJC2, HEPACAM, HSPD, HTRA, L2HGDH, LMNB, MLC, NOTCH3, PLP, POLR3A, POLR3B, PSAP, RNASEH2A, RNASEH2B, RNASEH2C, RNASET2, SAMHD, SCP2, SOX0, SUMF, TREX, TUBB4A MLPA 7 ABCD, ASPA, L2HGDH, LMNB, MLC, 070 NOTCH3, PLP Limb-Girdle Muscular Dystrophy Menkes Disease 27 ANO5, CAPN3, CAV3, DAG, DES, DNAJB6, 338 DYSF, FKTN, GMPPB, HNRNPDL, ISPD, LMNA, MYOT, PLEC, POMGNT, POMK, POMT, POMT2, SGCA, SGCB, SGCD, SGCG, TCAP, TNPO3, TRAPPC, TRIM32, TTN MLPA 2 ANO5, CAPN3, DYSF, FKRP, LCAV3, MNA, 343 MYOT, SGCA, SGCB, SGCD, SGCG, ZMPSTE24 ATP7A 030 MLPA ATP7A Microcephaly 24 Mitochondrial Diseases AP4M, ASPM, CASC5, CASK, CDK5RAP2, CENPJ, CEP63, CEP35, CEP52, EFTUD2, IER3IP, KIF, MCPH, NDE, NHEJ, PAFAHB, PCNT, PNKP, POMT, SLC25A9, STIL, TUBB2B, TUBGCP6, WDR62 37 Mitochondrial Genome 030 / 33 AARS2, ABCB7, ACAD9, ACADL, ACADM, 34 ACADS, ACADVL, AFG3L2, AIFM, ALAS2, APTX, ATPAF2, ATP5FE, AUH, BCSL, BOLA3, C2orf65, CISD2, COA5, COQ2, COQ6, COQ9, COQ8A, COX0, COX5, COX6B, CPTA, CPT2, DARS2, DGUOK, DLAT, DLD, DNAJC9, DNML, ETFA, ETFB, ETFDH, ETHE, FASTKD2, FBP, FH, FOXRED, G6PC, GAMT, GATM, GFER, GFM, GYS2, HARS2, HLCS, HADH, HADHA, HSPD, ISCU, LRPPRC, MFN2, MPV7, MRPS6, MRPS22, MTFMT, MTPAP, NDUFA, NDUFA0, NDUFA, NDUFA2, NDUFA2, NDUFAF, NDUFAF2, NDU- FAF3, NDUFAF4, NDUFAF5, NDUFB3, NDUFB9, NDUFS, NDUFS2, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFV, NDUFV2, NFU, NUBPL, OPA, OPA3, PC, PDHA, PDHB, PDHX, 34 Vaksali 7A, 5040 Tartu, Estonia
14 Mitochondrial Diseases Asper Neurogenetics 33 PDP, PDSS, PDSS2, PDX, POLG, POLG2, PUS, RARS2, REEP, RRM2B, SARS2, SCO, SCO2, SDHA, SDHAF, SETX, SLC9A3, SLC25A20, SLC25A3, SLC25A4, SLC6A8, SLC37A4, SOD, SPG7, SUCLA2, SUCLG, SURF,TACO, TAZ, TIMM8A, TK2, TMEM26A, TMEM70, TRMU, TSFM, TTC9, TUFM, TWNK, TYMP, UQCRB, UQCRQ, WFS, YARS2 34 MLPA 0 DGUOK, MPV7, POLG, POLG2, RRM2B, 70 SLC25A4, SUCLA2, SUCLG, TK2, TWNK Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke-Like Episodes (MELAS Syndrome) / MT-TL 87 Neurodegeneration with Brain Iron Accumulation 0 ATP3A2, COASY, C9orf2, CP, DCAF7, FA2H, 05 FTL, PANK2, PLA2G6, WDR45 MLPA 2 PANK2, PLA2G6 Parkinson s Disease 22 ADHC, ATP3A2, ATP6AP2, ATXN2, DNAJC6, EIF4G, FBXO7, GBA, GIGYF2, HTRA2, LRRK2, MAPT, PARK7, PINK, PLA2G6, PRKN, SLC6A3, SNCA, SNCB, TBP (excluding exon 3), UCHL, VPS35 34 MLPA 7 GCH, LRRK2, PARK7, PINK, PRKN, SNCA, 70 UCHL Short Chain Acyl-CoA Dehydrogenase (SCAD) Deficiency Smith-Lemli-Opitz Syndrome ACADS 55 DHCR7 525 Spinocerebellar Ataxias 66 ABCB7, ABHD2, ACO2, ADCK3 (COQ8A), 34 AFG3L2, ANO0, APTX, ATCAY, ATM, ATP8A2, CASK, CCDC88C, CLCN2, CLN5, C0orf2 (TWNK), CWF9L, CYP27A, DARS2, FXN, GOSR2, GRM, DNMT, EEF2, ELOVL4, ELOVL5, FGF4, FLVCR, ITPR, KCNC3, KCND3, KCNJ0, LAMA, NOP56, NPC, NPC2, OPHN, PDYN, PHYH, PNKP, PNPLA6, POLG, PRKCG, RUBCN (KIAA0226), PTFA, RNF26, SACS, SETX, SIL, SLC9A, SLC9A6, SLC52A2, SNX4, SPTBN2, STUB, SYNE, SYT4, TTBK2, TDP, TGM6, TMEM240, TPP, TTPA, TUBB4A, WFS, WWOX, ZNF592 Repeat Expansion Analysis 2 ATXN, ATXN2, ATXN3, ATXN7, ATXN8OS, ATXN0, ATN, BEAN, CACNAA, FXN, NOP56, PPP2R2B, TBP Tuberous Sclerosis 2 TSC, TSC2 803 MLPA 2 TSC, TSC Vaksali 7A, 5040 Tartu, Estonia
15 Asper Neurogenetics Very Long Chain Acyl-Coenzyme A Dehydrogenase (VLCAD) Deficiency Wilson Disease ACADVL 55 MLPA ACADVL ATP7B 773 MLPA ATP7B Whole Exome (WES) Whole Genome (WGS) Service includes DNA extraction Genotyping Bioinformatic analysis of detected variants Detected variants available in Excel format (on request) Validation of phenotype/diagnosis associated known or possibly pathogenic variants Clinical and biological interpretation Results delivery by registered mail (on request) TAT 2-9 weeks, excl. WES and WGS 5 weeks Online ordering, specimen requirements and shipping instructions are available at Vaksali 7A, 5040 Tartu, Estonia
16 Asper Otogenetics Alport Syndrome 3 COL4A3, COL4A4, COL4A5 030 MLPA COL4A5 Aminoglycoside-Induced Deafness / MT-RNR 87 Branchiootorenal Syndrome 3 EYA, SIX, SIX5 288 MLPA EYA Jervell and Lange-Nielson Syndrome Palmoplantar Keratoderma with Deafness 2 KCNE, KCNQ 773 GJB2 257 Pendred Syndrome Sensorineural Hearing Loss SLC26A4 773 MLPA SLC26A4 by GJB2, GJB3, GJB6, KCNQ4, MYO7A, MYO5A, 450 MT-RNR, MT-TS, SLC26A4, SLC26A5, TMC ACTG, ATP2B2, ATP6VB, BSND, CCDC50, CDH23, CEACAM6, CIB2, CLDN4, CLRN, COCH, COLA2, CRYM, DFNA5, DFNB3, DFNB59, DIABLO, DIAPH, DIAPH3, ESPN, ESRRB, EYA4, FOXI, GIPC3, GJB2, GJB3, GJB6, GPR98, GPSM2, GRHL2, GRXCR, HGF, ILDR, KCNJ0, KCNQ4, LHFPL5, LOXHD, LRTOMT, MARVELD2, MIR96, MSRB3, MYH4, MYH9, MYO5A, MYOA, MYO3A, MYO6, MYO7A, OTOA, OTOF, PCDH5, PDZD7, POU3F4, POU4F3, PRPS, PTPRQ, RDX, SERPINB6, SIX, SLC7A8, SLC26A4, SLC26A5, SMPX, STRC, TECTA, TJP2, TMC, TMIE, TMPRSS3, TPRN, TRIOBP (excluding exon 7), TRMU, USH2A, USHC, USHG, WFS GJB2 257 Stickler Syndrome 6 COL2A, COLA, COLA2, COL9A, COL9A2, 030 COL9A3 MLPA COLA Treacher-Collins Syndrome 3 POLRC, POLRD, TCOF 030 MLPA TCOF Vaksali 7A, 5040 Tartu, Estonia
17 Usher Syndrome Zellweger Spectrum Disorders by Asper Otogenetics 9 ADGRV (GPR98), CDH23, CLRN, MYO7A, 450 PCDH5, USH2A, USHC, USHG, WHRN (DFNB3) 20 ABHD2, ADGRV (GPR98), CDH23, CIB2, CLRN, 05 COL4A6, DSPP (excluding exon 5), GIPC3, HARS, KARS, LHFPL5, LOXHD, MYO7A, PCDH5, PDZD7, TNC, USH2A, USHC, USHG, WHRN (DFNB3) MLPA USH2A MLPA PCDH5 Waardenburg Syndrome 6 EDN3, EDNRB, MITF, PAX3, SNAI2, SOX0 030 MLPA 3 MITF, PAX3, SOX0 4 PEX, PEX2, PEX3, PEX5, PEX6, PEX7, PEX0, 05 PEX2, PEX3, PEX4, PEX6, PEX9, PEX26, PHYH Whole Exome (WES) Whole Genome (WGS) Service includes DNA extraction Genotyping Bioinformatic analysis of detected variants Detected variants available in Excel format (on request) Validation of phenotype/diagnosis associated known or possibly pathogenic variants Clinical and biological interpretation Results delivery by registered mail (on request) TAT 2-9 weeks, excl. WES and WGS 5 weeks Online ordering, specimen requirements and shipping instructions are available at Vaksali 7A, 5040 Tartu, Estonia
18 HEMATOLOGY Asper Hematology Alpha-Thalassemia PCR 2/7 HBA, HBA2 9 MLPA 2 HBA, HBA2 Beta-Thalassemia, Sickle Cell Disease HBB 257 MLPA HBB Fanconi Anemia 7 BRCA2, BRIP, ERCC4, FANCA, FANCB, FANCC, 05 FANCD2, FANCE, FANCF, FANCG, FANCI, FANCL, FANCM, PALB2, RAD5C, SLX4, XRCC2 MLPA 4 FANCA, FANCB, FANCD2, PALB2 070 Hereditary Sideroblastic Anemia 9 ABCB7, ALAS2, GLRX5, HSPA9, PUS, SLC9A2, 338 SLC25A38, TRNT, YARS2 Thrombocytopenia 4 ADAMTS3, ANKRD26, CYCS, GATA, GPBA, 070 GPBB, GP9, ITGA2B, ITGB3, MASTL, MPL, MYH9, RUNX, WAS Whole Exome (WES) Whole Genome (WGS) Service includes DNA extraction Genotyping Bioinformatic analysis of detected variants Detected variants available in Excel format (on request) Validation of phenotype/diagnosis associated known or possibly pathogenic variants Clinical and biological interpretation Results delivery by registered mail (on request) TAT 2-9 weeks, excl. WES and WGS 5 weeks Online ordering, specimen requirements and shipping instructions are available at Vaksali 7A, 5040 Tartu, Estonia
19 Asper Dysmorphology Brain malformations 47 ACTB, ACTG, ADGRG, AHI, AKT3, AMPD2, AMT, AP4M, ARFGEF2, ARL3B, ARX, ASPM, ATP6V0A2, ATR, ATRX, B9D, B3GALNT2, B4GAT, CASK, CC2D2A, CCND2, CDK5RAP2, CENPJ, CEP35, CEP290, CEP52, CEP63, CEP4, CHMPA, CLP, C5orf42, CREBBP, CUL4B, DCX, DHCR7, DHCR24, DLAT, DLD, DYNCH, ETFA, EFTUD2, ERMARD, ETFB, ETFDH, EXOSC3, 34 FAT4, FKRP, FKTN, FLNA, GCSH, GLDC, GMPPB, GPSM2, IER3IP, INPP5E, ISPD, KIF, KIF7, KIF2A, KIFBP, KIF5C, KNL, LAMA2, LAMB, LAMC3, LARGE, MCPH, MECP2, MKS, NBN, NDE, NHEJ, NPHP*, OCLN, OFD, OPHN, PAFAHB, PCNT, PDHA, PDHB, PDHX, PDP, PEX, PEX2, PEX3, PEX5, PEX6, PEX0, PEX2, PEX3, PEX4, PEX6, PEX9, PEX26, PIEZO2, PIK3R2, PNKP, POMGNT, POMGNT2, POMK, POMT, POMT2, PQBP, RAB8, RAB3GAP, RAB3GAP2, RARS2, RELN, RPGRIPL, RTTN, SEPSECS, SLC2A6, SLC25A9, SNAP29, SRD5A3, SRPX2, STIL, TBCD20, TCF4, TCTN, TCTN2, TCTN3, TMEM23, TMEM237, TMEM26, TMEM38, TMEM67, TMEM5, TSEN2, TSEN34, TSEN54, TTC2B, TUBAA, TUBA8, TUBB, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBG, TUBGCP6, VLDLR, VRK, WASHC5, WDR62, ZEB2, ZNF423 * - 250kb deletion in the heterozygous state is not with the test Craniosynostosis, 7 FGFR, FGFR2, FGFR3, ILRA, MSX2, RECQL4, 05 TWIST MLPA TWIST Microcephaly AP4M, ASPM, CASK, CDK5RAP2, CENPJ, CEP63, CEP35, CEP52, EFTUD2, IER3IP, KIF, KNL (CASC5), MCPH, NDE, NHEJ, PAFAHB, PCNT, PNKP, POMT, SLC25A9, STIL, TUBB2B, TUBGCP6, WDR62 Noonan Syndrome 3 BRAF, CBL, HRAS, KAT6B, KRAS, MAP2K, 05 MAP2K2, NRAS, PTPN, RAF, SHOC2, SOS, SPRED Skeletal Ciliopathies 23 CEP20, COMP, CSPP, DYNC2H, DYNC2LI, EVC, EVC2, FGFR3, IFT43, IFT22, IFT52, IFT80, IFT40, IFT72, KIAA0586, NEK, TCTEXD2, 546 TCTN3, TTC2B, WDR9, WDR34, WDR35, WDR60 Vaksali 7A, 5040 Tartu, Estonia
20 Asper Dysmorphology Skeletal Dysplasia, 5 ALPL, COL2A, ESCO2, FGFR, FGFR2, FGFR3, 05 ILRA, MSX2, RECQL4, ROR2, SLC26A2, SOX9, TRIP, TWIST, WNT5A MLPA COL2A MLPA TWIST Smith-Lemli-Opitz Syndrome DHCR7 525 Whole Exome (WES) Whole Genome (WGS) Service includes DNA extraction Genotyping Bioinformatic analysis of detected variants Detected variants available in Excel format (on request) Validation of phenotype/diagnosis associated known or possibly pathogenic variants Clinical and biological interpretation Results delivery by registered mail (on request) TAT 2-9 weeks, excl. WES and WGS 5 weeks Online ordering, specimen requirements and shipping instructions are available at Vaksali 7A, 5040 Tartu, Estonia
21 ENDOCRINOLOGY Asper Endocrinology Androgen Insensitivity Syndrome Combined Pituitary Hormone Deficiency Familial Hypocalciuric Hypercalcemia Hypothyroidism and Thyroid Hormone Resistance Maturity Onset Diabetes of the Young (MODY) Thyroid Dyshormonogenesis Whole Exome (WES) MLPA AR 6 HESX, LHX3, LHX4, OTX2, POUF, PROP MLPA 7 GH, GHRHR, HESX, LHX3, LHX4, POUF, PROP AR MLPA CASR 22 DUOX2, DUOXA2, GNAS, HESX, IYD, NKX2-, 070 NKX2-5, PAX8, POUF, PROP, SECISBP2, SLC5A5, SLC6A2, SLC26A4, TG, THRA, THRB, TPO, TRHR, TSHB, TSHR MLPA GNAS 5 ABCC8, BLK, CEL, GCK, HNFA, HNF4A, HNFB, INS, KCNJ, KLF, NEUROD, PAX4, PDX, RFX6, ZFP57 MLPA 0 CEL, GCK, HNFA, HNF4A, HNFB, INS, KLF, NEUROD, PAX4, PDX 6 CASR 535 DUOX2, DUOXA2, IYD, SLC5A5, TG, TPO MLPA 5 FOXE, NKX2-, PAX8, TPO, TSHR Whole Genome (WGS) Service includes DNA extraction Genotyping Bioinformatic analysis of detected variants Detected variants available in Excel format (on request) Validation of phenotype/diagnosis associated known or possibly pathogenic variants Clinical and biological interpretation Results delivery by registered mail (on request) TAT 2-9 weeks, excl. WES and WGS 5 weeks Online ordering, specimen requirements and shipping instructions are available at Vaksali 7A, 5040 Tartu, Estonia
22 METABOLIC DISORDERS Asper Metabolic Disorders Citrin Deficiency SLC25A3 803 Citrullinemia, type 2 ASS 803 Fatty Acid Oxidation Disorder Glutaric Aciduria, type Glutaric Aciduria, type 2 Glycogen Storage Disease 2 ACAD9, ACADM, ACADS, ACADVL, CPTA, 070 CPT2, ETFA, ETFB, ETFDH, GLUD, HADH, HADHA, HADHB, HMGCL, HMGCS2, HSD7B0, LPIN, PPARG, SLC22A5, SLC25A20, TAZ MLPA SLC22A5 25 GCDH EFTA AGL, ALDOA, ENO3, FBP, G6PC, GAA, GBE, GYG, GYS, GYS2, LAMP2, LDHA, PFKM, PGAM2, PGK, PGM, PHKA, PHKA2, PHKB, PHKG2, PRKAG2, PYGL, PYGM, SLC2A2, SLC37A4 Hemochromatosis 5 HAMP, HFE, HFE2, SLC40A, TFR Lysosomal Storage Disease 50 AGA, ARSA, ARSB, ASAH, CLN3, CLN5. CLN6, 338 CLN8, CTNS, CTSA, CTSC, CTSD, CTSK, DNAJC5, FUCA, GAA, GALC, GALNS, GBA, GLA, GLB, GM2A, GNPTAB, GNPTG, GNS, GUSB, HEXA, HEXB, HGSNAT, HYAL, IDS, IDUA, LAMP2, LIPA, MAN2B, MANBA, MCOLN, MFSD8, NAGA, NAGLU, NEU, NPC, NPC2, PPT, PSAP, SGSH, SLC7A5, SMPD, SUMF, TPP MLPA GLA MLPA IDS MLPA 2 NPC, NPC2 MLPA HEXA Metabolic Myopathy and Rhabdomyolysis 43 ABHD5, ACAD9, ACADM, ACADVL, AGL, ALDOA, AMPD, CAV3, CPT2, ENO3, ETFA, ETFB, ETFDH, GAA, GBE, GYG, GYS, HADHA, HADHB, ISCU, LDHA, LPIN, OPA, OPA3, PFKM, PGAM2, PGK, PGM, PHKA, PNPLA2, PRKAG2, POLG, POLG2, PYGM, RRM2B, RYR, SLC22A5, SLC25A20, SUCLA2, TAZ, TK2, TWNK (C0ORF2), TYMP 070 Methylmalonic Aciduria and Homocystinuria 23 ABCD4, ACSF3, AMN, CBS, CD320, CUBN, GIF, 070 IVD, LMBRD, MCEE, MLYCD, MMAA, MMAB, MMACHC, MMADHC, MTHFR, MTR, MTRR, MUT, SUCLA2, SUCLG, TCN, TCN2 MLPA MLYCD Vaksali 7A, 5040 Tartu, Estonia
23 METABOLIC DISORDERS Asper Metabolic Disorders Porphyria MLPA 9 7 ALAD, ALAS2, CPOX, FECH, HFE, HMBS, PPOX, UROD, UROS ALAD, CPOX, FECH, HMBS, PPOX, UROD, UROS Short-Chain Acyl-CoA Dehydrogenase (SCAD) Deficiency Smith Lemli Opitz Syndrome Whole Exome (WES) ACADS Urea Cycle Disorder 0 ARG, ASL, ASS, CPS, NAGS, OAT, OTC, 070 SLC7A7, SLC25A3, SLC25A5 MLPA OTC Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficiency DHCR7 ACADVL Whole Genome (WGS) Service includes DNA extraction Genotyping Bioinformatic analysis of detected variants Detected variants available in Excel format (on request) Validation of phenotype/diagnosis associated known or possibly pathogenic variants Clinical and biological interpretation Results delivery by registered mail (on request) TAT 2-9 weeks, excl. WES and WGS 5 weeks Online ordering, specimen requirements and shipping instructions are available at Vaksali 7A, 5040 Tartu, Estonia
Comprehensive genetic testing for hearing and vision loss
Comprehensive genetic testing for hearing and vision loss Hearing and vision loss can result from both genetic and non-genetic etiologies In general, there is a genetic basis for up to 50% of prelingual
More informationSubject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained:
TEST PERFORMED Whole exome sequencing (WES) with Focused Diagnostic Panel(s): Neuropathy, Leukodystrophy, Myopathy See below for a complete list of genes analyzed. RESULTS 1 sequence variant with potential
More informationTargeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels
Targeted s and Methodology Details for Epilepsy/Seizure tic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Epilepsy/Seizure tic Panels Epilepsy Expanded Panel Epilepsy Expanded
More informationUKGTN Testing Criteria
UKGTN Testing Criteria Approved name and symbol of disease/condition(s): Retinal Degeneration panel test Approved name and symbol of gene(s): a panel of 105 genes, variants of which have been shown to
More informationRequisition for DNA Testing. Reason for Referral: Patient Information: INCOMPLETE REQUESTS WILL BE BANKED. Test Requests: Sample Collection:
Reason for Referral: Diagnostic Testing: Affected Unaffected Carrier testing/known Family Mutation Name of index case in the family (include copy of report): Date of Birth: Relationship to this patient:
More informationdevseek (Sequence(Analysis(Panel(for(Neurodevelopmental(Disorders
ACSL4 Mental/retardation,/XBlinked/63 XLBR ADSL Adenylosuccinase/Deficiency AR AFF2 Mental/retardation,/XBlinked,/FRAXE/type XLBR ALG6 Congenital/disorder/of/glycosylation/type/Ic AR ANK3 Mental/retardation,/autosomal/recessive/37
More informationRequest for expedited Result
London Health Sciences Centre Molecular Genetics Laboratories Requisition for DNA Testing DACC002 REV 20170815 AUTHORIZED SIGNATURE IS REQUIRED INCOMPLETE REQUESTS WILL BE BANKED Molecular Genetics Laboratory
More informationVariant prioritization
Variant prioritization University of Cambridge Marta Bleda Latorre Cambridge, UK mb2033@cam.ac.uk 30th September 2014 Research Assistant at the Department of Medicine University of Cambridge Cambridge,
More informationEnabling Informed Clinical Decisions with Deep Insights. Routine Multi-gene Testing for Inherited Neuromuscular Disorders
Enabling Informed Clinical Decisions with Deep Insights Routine Multi-gene Testing for Inherited Neuromuscular Disorders Introduction Multi-gene Testing for Inherited Neuromuscular Disorders Inherited
More informationVariant association and prioritization
Variant association and prioritization Edinburgh Genomics Marta Bleda Latorre Edinburgh, UK mb2033@cam.ac.uk 23rd October 2015 Research Assistant at the Department of Medicine University of Cambridge Cambridge,
More informationCOMPLETE A FORM FOR EACH SAMPLE SUBMITTED ETHNIC BACKGROUND REPORTING INFORMATION
DATE SAMPLE DRAWN: SAMPLE TYPE: BLOOD OTHER (SPECIFY): COMPLETE A FORM FOR EACH SAMPLE SUBMITTED PATIENT FIRST NAME: LAST NAME: DOB: SEX: M F UNKNOWN ADDRESS: HOME PHONE: ( ) WORK: ( ) EUROPEAN CAUCASIAN
More informationLMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene
LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene ACTA2* Exon 02-09 NM_001613.2 DSG2* Exon 01-15 NM_001943.3 ACTC1* Exon 01-06 NM_005159.4 DSP* Exon 01-24 NM_004415.2 APC* Exon 01-15
More informationCOMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS
COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS MITOCHONDRIAL DISORDERS NGS PANELS MITOCHONDRIAL DISORDERS NGS PANELS Name Test code Gene Name Mitome200-Nuclear 2086 (164 nuclear genes) AARS2, ACACA,
More informationSupplementary appendix
Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Ellingford JM, Sergouniotis PI, Lennon R, et
More informationAchromatopsia NGS 6 ATF6, CNGA3, CNGB3, GNAT2, PDE6C, PDE6H ARMS2, CFH Sequencing PAX6
Disease/Condition name Method No of Asper Ophthalmics Achromatopsia 6 ATF6, CNGA3, CNGB3, GNAT2, PDE6C, PDE6H 05 Age-related Macular Degeneration 2 ABCA4, ARMS2, C2, C3, C9, CCR3, CFB, CFH, 995* CFI, CST3,
More informationIllumina Clinical Services Laboratory
Illumina Clinical Services Laboratory CLIA Certificate No.: 05D1092911 Illumina Clinical Services Laboratory TruGenome Predisposition Screen Requisition Form The TruGenome Predisposition Screen is intended
More informationPhenotype Report. Num. Positions Not Called (Missing data) Num. Variants Assessed
Report Date: August 19, 2015 Software Annotation Version: 8 Report Name: NA12144 NW European Genome : NA12144_S1 Sequencing Provider: Illumina Sequencing Type: Exome : Retinitis Pigmentosa Description:
More informationGenomic Service List
Document ID: MBG-C009 Effective Date: 10 Jan 018 Page: 1 of 5 WHOLE GENOME SEQUENCING Human Whole Genome Sequencing 1 HGG-15 Human Whole Genome Sequencing HGG-157 (FASTQ data only) WHOLE EXOME SEQUENCING
More informationPRICE AND TEST LIST January 4, 2018 (by Test Code)
Test Code Test Description TAT Price 2018 CPT Codes WHOLE EXOME SEQUENCING WES001 MNG Exome TM Trio Sequencing and Copy Number Analysis + mtdna (Proband + 2 Family Members) 2-4 Weeks $6,900.00 81415, 81416,
More informationPRICE AND TEST LIST August 24, 2018 (by Test Code)
Test Code Test Description TAT Price 2018 CPT Codes WHOLE GENOME SEQUENCING WGS001 MNGenome TRIO Sequencing 2-6 Weeks Call 81425, 81426 x2 WGS003 MNGenome Proband Only Sequencing 2-6 Weeks Call 81425 WHOLE
More informationINVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS
INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS A broad menu covering the vast majority of inherited metabolic disorders that are routinely tested as part of state newborn screening
More informationSupplemental Information. Whole-Genome Sequencing. of a Healthy Aging Cohort
Cell, Volume 165 Supplemental Information Whole-Genome Sequencing of a Healthy Aging Cohort Galina A. Erikson, Dale L. Bodian, Manuel Rueda, Bhuvan Molparia, Erick R. Scott, Ashley A. Scott-Van Zeeland,
More informationDNA Genetic Cancer Risk Test. Test Report
Test Report CONTENTS SECTION 1 1-1. Customer Information 1-2. Test Report Summary 1-3. Test Report Details 1-4. List of Cancers / Tumors Tested SECTION 2 2-1. About the Test 2-2. References 1 CL0040-1_B
More informationAddress City State Zip Phone. the hospital/facility:
PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:
More informationCentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION
CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION CentoCancer our most comprehensive oncogenetics panel for hereditary mutations Hereditary pathogenic variants confer an increased risk of developing
More informationREQUEST FOR MOLECULAR GENETIC TESTING
PATIENT DATA CLINIC/DEPARTMENT/PRACTICE Human Genetics Diagstics Laboratory for Cytogenetics and Molecular Genetics Medical director: Prof. Dr. med. Dr. Judith Fischer Please send samples to: Institut
More informationNutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:
NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status
More informationFeedback of results. Report via to NTGMC inbox. Review by GMC clinician
Genetic deafness Maria Bitner-Glindzicz Genetics and Genomic Medicine Programme UCL Institute of Child Health, UCL Ear Institute, and Great Ormond Street Hospital for Children Feedback of results Report
More informationProposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider
Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider TEST DISEASE/CONDITION POPULATION TRIAD Submitting laboratory: 1. Disease/condition approved name and
More informationAnalysis and interpretation of genetic NEUROLOGICAL DISORDERS
, PH 1, POLG M, RAPSN, R CA, SGCB, SGC A3, SLC25A4, SLC5 1, SYNE2, SYT2, TAC NNT1, TNNT3, T N 4, TRIM63, TRIP4, AS39, VMA21, VPS S, ACADVL, ACTA1, AD 1, ANO5, ASCC1, ATP2A CACNA1S, CAPN3, CASQ P1, COL12A1,
More informationMitochondrial Disorders Genetic Testing
Mitochondrial Disorders Genetic Testing A Comprehensive Guide 1 Introduction Mitochondrial disorders are a group of related, clinically diverse, genetic diseases with a prevalence of 1/5,000 to 1/8,500
More informationBewegingsstoornisssen genpanel v1 (203 genen)
Bewegingsstoornisssen genpanel v1 (203 genen) ABCB7 99,8 Anemia, sideroblastic, with ataxia, 301310 ABCD1 98,7 Adrenoleukodystrophy, 300100 Adrenomyeloneuropathy, adult, 300100 ABHD12 93,8 Polyneuropathy,
More informationHigh Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)
CarrierMap Expanded v3 Panel: 314 Diseases CarrierMap screen for 316 diseases including DMD. Disease Groups High Impact Treatment Benefits X-Linked Moderate Impact These diseases have a significant impact
More informationA CANCER GENETICIST S (2 ND ) BEST FRIEND IS THEIR PATHOLOGIST. Dr Alan Donaldson Consultant in Clinical Genetics St Michaels Hospital Bristol
A CANCER GENETICIST S (2 ND ) BEST FRIEND IS THEIR PATHOLOGIST Dr Alan Donaldson Consultant in Clinical Genetics St Michaels Hospital Bristol Topics to be covered How pathology contributes to genetic diagnosis
More informationDivision of Genomic Diagnostics GENOMIC DIAGNOSTICS TEST REQUISITION *For Cancer tests please use the Cancer Test Requisition.
Page 1 of 10 SHIP TO: Children s Hospital of Philadelphia, Genomic Diagnostics Laboratory, 3615 Civic Center Blvd., Abramson Research Center, 714, Philadelphia, PA 19104-4302 - Phone: (215) 590-4452 Patient
More informationWhole exome sequencing Gene package Hearing impairment version 2,
Whole Exome Sequencing Gene package Hearing impairment, version 2, 23 9 2016 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run
More informationGenetic Defect Underlying Progressive Blindness Uncovered by Strand s Clinical Exome Test
CASE STUDY Genetic Defect Underlying Progressive Blindness Uncovered by Strand s Clinical Exome Test Patient Profile Swati Koparkar*, a 33-year-old owner of a handicrafts boutique had been experiencing
More information4978 Santa Anita Ave Temple City, CA (p) (f)
Patient Information Doe, Jane Sex: F MR#: FD Patient#: FT-PT00000 Accession: FT-00000 Test#: FT-00000 Specimen Type: Blood (EDTA) Collection Date: Aug 01, 2017 Partner Information Not Tested Accession:
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:
More informationInformed Consent Columbia Whole Genome or Whole Exome Sequencing
Informed Consent Columbia Whole Genome or Whole Exome Sequencing Please read the following form carefully and discuss with your ordering physician before signing consent. This consent is intended for the
More informationLions and Tigers and Bears.Oh My!
Lions and Tigers and Bears.Oh My! TAKING THE FEAR OUT OF GENETIC TESTING Lisa Butterfield, MS, CGC Genetic Counselor Clinical Assistant Professor University of Kansas Health System Why is Genetic Testing
More informationEvolve FamilyReady Carrier Screen
Evolve FamilyReady Carrier Screen Accurate & Comprehensive Expanded Carrier Screen of >200 genes for the most relevant genetic disorders for all ethnicities. Achromatopsia CNGB3 X-linked Adrenoleukodystrophy
More informationCilioPathy panel. 3-Jul-2018 (102 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID
versie 3-Jul-2018 (102 genen) CilioPathy panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern AHI1 608894 Joubert
More informationAccount # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5
Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Molecular Genetics Test Requisition
More informationResidual risks by ethnicity
Residual risks by ethnicity This table displays residual risks after a negative result for each of the genes and corresponding disorders. If a patient is reported to be a carrier of a disease, their residual
More informationGermline Multigene Panel Testing in Oncology: Genetic Counseling Perspective
Germline Multigene Panel Testing in Oncology: Genetic Counseling Perspective Sarah L. Campian, MS CGC Certified Genetic Counselor Nancy & James Grosfeld Cancer Genetics Center Objectives Identify patients/families
More informationNEXT GENERATION SANGER SEQUENCING PLATFORMS (NGS)
NEXT GENERATION SANGER SEQUENCING PLATFORMS (NGS) Category Disease Category Disease Number of Genes Genes Comment Test Specification Price in Next Generation and Sanger Sequencing Platforms (NGS) Cancer
More informationThe University of Chicago Genetic Services Laboratories
Aceruloplasminemia testing CP sequencing Aceruloplasminemia CP deletion/duplication Albinism testing Albinism Sequencing Panel (20 genes Albinism Deletion/Duplication Panel (20 genes Alstrom syndrome testing
More informationPromo Code (if applicable) mutation description. 1. Name of Physician. 2. Clinic. 3. Department. 4. Street. 5. Zip Code / Town. 6.
tic Diagnostics A. Analysis Requested 1. Test(s)/(s) 1.1 Single Sequencing 1.2 NGS Panel 1.3 NGS Panel Plus 1.4 NGS Panel Genomic 1.5 Deletion/Duplication Analysis B. Patient Name (Label) 1. Surname Promo
More informationPromo Code (if applicable) ... mutation description. 1. Name of Physician. 2. Clinic. 3. Department. 4. Street. 5. Zip Code / Town. 6.
Genetic Diagnostics A. Analysis Requested 1. Test(s)/Gene(s) 1.1 Single Gene Sequencing 1.2 NGS Panel 1.3 NGS Panel Plus 1.4 NGS Panel Genomic 1.5 Deletion/Duplication Analysis 1.6 Repeat Expansion 1.7
More informationpatient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention
patient guide CancerNext-Expanded genetic testing for hereditary cancer Because knowing your risk can mean early detection and prevention Know the Basics Cancer occurs in about 1 in 3 adults in their lifetime
More informationWhole exome sequencing Gene package Hearing impairment version 3.1,
Whole Exome Sequencing Gene package Hearing impairment, version 3.1, 22 11 2017 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced
More informationERN EpiCARE. A European Reference Network for Rare and Complex Epilepsies. Petr Marusic Motol University Hospital, Prague
ERN EpiCARE A European Reference Network for Rare and Complex Epilepsies Petr Marusic Motol University Hospital, Prague Disclosure I have no actual or potential conflict of interest in relation to this
More informationcataract panel 16-Apr-2018 (63 genen) Centrum voor Medische Genetica Gent versie OMIM gene ID
versie 16-Apr-2018 (63 genen) cataract panel Centrum voor Medische Genetica Gent Gene OMIM gene ID AGK 610345 ALDH18A1 138250 Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance
More informationUtilization of the MiSeq in a clinical lab. Tony Krentz, PhD PreventionGenetics
Utilization of the MiSeq in a clinical lab Tony Krentz, PhD PreventionGenetics PreventionGenetics Founded in 2004 in Marshfield, Wisconsin by James Weber ~90 employees Largest test menu in US Vision: Disease
More informationEpilepsy. Genetic Test Submission Guide. 2. Samples. 1. Forms. 3. Ship RESULTS. impactgenetics.com
Epilepsy Genetic Test Submission Guide 1. Forms 2. Samples Form 1d: If applicable Form 1b: Requisition Form Form 1a: Informed Consent 3. Ship RESULTS Impact Genetics, Dynacare 4-1100 Bennett Rd. Bowmanville,
More informationOXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018
OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018 Please note that there is a 15% surcharge for Non-NHS patients. Highly specialised services (HSS) are indicated. Note: This test
More informationSCOPE OF ACCREDITATION TO ISO 15189:2012. PREVENTION GENETICS 3800 S. Business Park Ave. Marshfield, WI Jessica Kayhart Phone:
SCOPE OF ACCREDITATION TO ISO 15189:2012 PREVENTION GENETICS 3800 S. Business Park Ave. Marshfield, WI 54449 Jessica Kayhart Phone: 715 387 0484 CLINICAL Valid To: September 30, 2018 Certificate Number:
More informationDivision of Genomic Diagnostics GENOMIC DIAGNOSTICS TEST REQUISITION *For Cancer tests please use the Cancer Test Requisition.
Page 1 of 8 SHIP TO: Children s Hospital of Philadelphia, Genomic Diagnostics Laboratory, 3615 Civic Center Blvd., Abramson Research Center, 714, Philadelphia, PA 19104-4302 - Phone: (215) 590-4452 PATIENT
More informationHERES Carrier Screening TEST
LISTADO DE ENFERMEDADES ANALIZADAS HERES Carrier Screening TEST 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 17-Alpha-Hydroxylase Deficiency 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency
More informationA European Reference Network for rare and complex epilepsies. J Helen Cross Coordinator
A European Reference Network for rare and complex epilepsies J Helen Cross Coordinator The epilepsies a group of rare diseases Early myoclonic encephalopathy PIGA, SETBP1, SIK1, SLC25A22 Dravet syndrome
More informationMEDICAL POLICY Genetic Testing
POLICY.........PG0041 EFFECTIVE......01/01/12 LAST REVIEW... 03/24/17 MEDICAL POLICY Genetic Testing GUIDELINES This policy does not certify benefits or authorization of benefits, which is designated by
More informationGENETICS IN HEREDITARY NEUROPATHY
GENETICS IN HEREDITARY NEUROPATHY ERNESTO ALONSO, SWETHA JASTI,MAZEN M.DIMACHKIE, RICHARD J. BAROHN, MELANIE GLENN, OMAR JAWDAT, JEFFREY STATLAND, LAURA HERBELIN, CONSTANTINE FARMAKIDIS,DUAA JABARI, MAMATHA
More informationLeistungsverzeichnis
Leistungsverzeichnis SYNLAB MVZ Humangenetik Mannheim Genetische Beratung / Molekulargenetische Diagnostik / Molekulare Zytogenetik / Abstammungsgutachten und Vaterschaftstest www.zhma.de Akkreditiert
More informationMOLECULAR SERVICES. mlabs.umich.edu
MOLECULAR SERVICES mlabs.umich.edu 800.862.7284 PICTURED ON LEFT IS MARWAN TAYEH, PH.D, CLINICAL ASSISTANT PROFESSOR, PEDIATRICS - GENETICS, ON RIGHT IS TODD ACKLEY, LABORATORY MANAGER MLabs is a full-service
More informationWhole Exome Sequencing (WES): Questions and Answers for Providers
Whole Exome Sequencing (WES): Questions and Answers for Providers 1. What is Whole Exome Sequencing?... 2 2. What is the difference between Whole Exome Sequencing (WES) and Whole Exome Sequencing Plus
More informationList of diseases covered by Cancer Predisposition NGS panel
List of diseases covered by Cancer Predisposition NGS panel Gene Condition AIP Pituitary adenoma 1, multiple types ALK Neuroblastoma, susceptibility to, 3 APC Adenomatous polyposis coli; Colorectal cancer,
More informationFamily Education and Support
Family Education and Support Key Topics First Aid Seizure Safety Sports Physical Activity Driving Familial Psychosocial Needs in Treating Pediatric Epilepsy Poll Question 1 Which of the following is not
More informationNeurogenetics User Manual
Neurogenetics User Manual Page 1 of 21 Address: Neurogenetics Unit 6 th Floor, Institute of Neurology Institute of Neurology Queen Square, London WC1N 3BG Tel No: 020 344 84250 (ext 84250 if internal)
More informationPANELES PARA ESTUDIOS GENÉTICOS
PANELES PARA ESTUDIOS GENÉTICOS Ante cualquier duda o consulta, puede escribirnos a: estudiosgeneticos@labmedicina.com EXÁMENES PARA CÁNCER HEREDITARIO Panel de Cáncer Hereditario - Principales Genes (37
More informationMAC-ASD panel. 16-Apr-2018 (59 genen) Centrum voor Medische Genetica Gent. versie. OMIM gene ID
versie 16-Apr-2018 (59 genen) MAC-ASD panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern ABCB6 605452 [Blood
More informationJocelyn Chapman, MD Division of Gynecologic Oncology. Julie S. Mak, MS, MSc Genetic Counselor Hereditary Cancer Clinic
Jocelyn Chapman, MD Division of Gynecologic Oncology Julie S. Mak, MS, MSc Genetic Counselor Hereditary Cancer Clinic Genetics underlies all cancers Somatic or tumor genetics Germline or inherited genetics
More informationLABHORIZONS. New Procedures A NEWSLETTER FOR CLIENTS
LABHORIZONS A NEWSLETTER FOR CLIENTS Volume XVII, No. 7 July 2017 New Procedures 5 HIAA, Plasma.................................. 504510 CPT 83497 Synonyms 5-hydroxyindoleacetic acid Use Plasma 5-hydroxy-indoleacetic
More informationRetinal dystrophies, genomic applications in diagnosis and prospects for therapy
Review Article Retinal dystrophies, genomic applications in diagnosis and prospects for therapy Benjamin M. Nash 1,2,3, Dale C. Wright 2,3, John R. Grigg 1, Bruce Bennetts 2,3, Robyn V. Jamieson 1,3 1
More informationClinical Laboratory Fee Schedule CY 2015 Updates June 9, 2014
Clinical Laboratory Fee Schedule CY 2015 Updates June 9, 2014 Please note that this listing includes the most recent codes provided by the American Medical Association (AMA), and that it is subject to
More informationClinical Diagnosis of Mendelian Disorders Using a Comprehensive Gene-Targeted Panel Test for Next-Generation Sequencing
Yonago Acta medica 2016;59:118 125 Original Article Clinical Diagnosis of Mendelian Disorders Using a Comprehensive Gene-Targeted Panel Test for Next-Generation Sequencing Tetsuya Okazaki,* Megumi Murata,
More informationSpieraandoeningen genpanel v2 (148 genen)
Spieraandoeningen genpanel v2 (148 genen) Gene ACADVL 99,8 VLCAD deficiency, 201475 ACTA1 99,1 Nemaline myopathy 3, autosomal dominant or recessive, 161800 Myopathy, actin, congenital, with excess of thin
More informationCataract and optic disk drusen in a patient with glycogenosis and di George syndrome: clinical and molecular report
Allegrini et al. BMC Ophthalmology (2017) 17:107 DOI 10.1186/s12886-017-0499-y CASE REPORT Cataract and optic disk drusen in a patient with glycogenosis and di George syndrome: clinical and molecular report
More informationReverse phenotyping: MCD Detection without clinical diagnosis. Diagnostic: NGS panels versus WES
Clinical Genetics Leading the way in genetic issues Reverse phenotyping: MCD Detection without clinical diagnosis Diagnostic: NGS panels versus WES Martina Wilke Laboratory Specialist Clinical Genetics
More informationNGS Panel Plus. Sequencing Sequencing + NGS based CNVs Del/Dup with MLPA. Clinic. Department. Street. ZIP Code/Town. Country. . Billing.
Promo Code (if applicable) Genetic Diagnostics (s)/gene(s)/panel(s): Analysis Requested Single Gene Sequencing Sequencing (Sanger) Sequencing (NGS) Sequencing + CNVs (with NGS) Del/Dup (MLPA or qpcr) Carrier
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:
More informationDiagnostic offer: Single gene diagnostic alphabetical list
AAAS AARS ABCA12 ABCA4 ABCC2 ABCC6 ABCC8 ABCC9 ABCD1 ABHD12 ABHD5 ACAD9 ACADM ACADS ACADSB ACADVL ACAT1 ACSF3 ACTA1 ACTA2 ACTB ACTC1 ACTG2 ACVR1 ACVR2B ACVR2B ACVRL1 ADA ADAMTS10 ADAMTS13 ADAMTS2 ADAMTSL2
More informationTest Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS
UNIVERSITY OF MINNESOTA PHYSICIANS OUTREACH LABS MOLECULAR DIAGNOSTICS (612) 273-8445 DATE: TIME COLLECTED: AM PM PCU/CLINIC: DIAGNOSIS (Dx) / DIAGNOSIS CODES (ICD-9) - OUTPATIENTS ONLY (1) (2) SPECIMEN
More informationCardioPathy panel. versie V4 (167 genen) Centrum voor Medische Genetica Gent
CardioPathy panel versie V4 (167 genen) Centrum voor Medische Genetica Gent Gene OMIM gene ID ABCC9 601439 Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern Atrial
More informationLeistungsverzeichnis
Leistungsverzeichnis SYNLAB MVZ Humangenetik Mannheim Genetische Beratung / Molekulargenetische Diagnostik / Molekulare Zytogenetik / Abstammungsgutachten und Vaterschaftstest www.zhma.de Akkreditiert
More informationMolecular Diagnostic Laboratory 18 Sequencing St, Gene Town, ZY Tel: Fax:
Molecular Diagnostic Laboratory 18 Sequencing St, Gene Town, ZY 01234 Tel: 555-920-3333 Fax: 555-920-3334 www.moldxlaboratory.com Patient Name: Jane Doe Specimen type: Blood, peripheral DOB: 04/05/1990
More informationJennifer Hauenstein Oncology Cytogenetics Emory University Hospital Atlanta, GA
Comparison of Genomic Coverage using Affymetrix OncoScan Array and Illumina TruSight Tumor 170 NGS Panel for Detection of Copy Number Abnormalities in Clinical GBM Specimens Jennifer Hauenstein Oncology
More informationDiagnostic and Treatment of Patients with Primary and Metastatic Breast Cancer
Diagnostic and Treatment of Patients with Primary and Metastatic Breast Cancer Breast Cancer Risk and Prevention Breast Cancer Risk and Prevention Versions 2003 2017: Schmutzler / Albert / Blohmer / Fasching
More informationWhole exome sequencing Gene package Epilepsy version 1,
Whole Exome Sequencing Gene package Epilepsy, version 1, 8 4 2015 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina
More informationThe Prior Authorization List
ADVANCING CLINICALLY APPROPRIATE LAB TECHNOLOGY AND SERVICES The Prior Authorization List For BlueCross BlueShield of South Carolina and BlueChoice HealthPlan 2018 Visit us at Avalonhcs.com BlueCross BlueShield
More informationRetNet panel. Microcornea, myopic chorioretinal atrophy, and telecanthus, (3), Autosomal recessive ADGRA No OMIM phenotype
versie 27-Feb-2018 (266 genen) RetNet panel Centrum voor Medische Genetica Gent Gene OMIM gene ID Associated phenotype, OMIM phenotype ID, phenotype mapping key and inheritance pattern ABCA4 601691 Cone-rod
More informationComprehensive Test Menu August 2018
Comprehensive Test Menu August 2018 Cancer brain tumors Brain tumors, hereditary BrainTumorNext: 27 genes 14-21 days 8847 Neurofibromatosis type 2 (NF2) NF2 14-21 days 9024 Schwannomatosis SMARCB1 14-21
More informationCARRIER SCREENING PANEL
1 / 6 1. WHAT IS THE CARRIER? The carrier screening panel is a genetic test that simultaneously analyses mutations in 298 genes which cause recessive inherited pathologies. Diseases with a recessive inheritance
More informationTargeted Agent and Profiling Utilization Registry (TAPUR ) Study. February 2018
Targeted Agent and Profiling Utilization Registry (TAPUR ) Study February 2018 Precision Medicine Therapies designed to target the molecular alteration that aids cancer development 30 TARGET gene alterations
More informationEthical Challenges of Genome-based Cancer Research: Return of individual research results
Ethical Challenges of Genome-based Cancer Research: Return of individual research results Gail P. Jarvik, M.D., Ph.D. Arno G. Motulsky Endowed Chair Medicine and Genome Sciences Head, Medical Genetics
More informationNGS in Diagnostics: a practical example in hereditary cardiomyopathies
NGS in Diagnostics: a practical example in hereditary cardiomyopathies Patricia Norambuena University Hospital Motol, Prague. 2 nd Faculty of Medicine, Charles University VEP Course - November 6 th - 8th,
More informationWhole exome sequencing Gene package Neurodegeneration version 3,
Whole Exome Sequencing Gene package Neurodegeneration, version 3, 30 7 2018 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced on
More informationSAMPLE. Carrier Screening Results Report v2.2 Page 1/8
MM480: Pan-Ethnic Carrier Screen - Targeted Mutation Panel Report Prepared For: Patient: Name: Date of Birth: IDs (Internal / External): Reported Gender: Reported Ethnicity: Sample: Sample Collection Date:
More informationInferring the Mammalian Cardiogenic Gene Regulatory Network. Jason Bazil 10/18/13 Cardiac Physiome Workshop 2013
Inferring the Mammalian Cardiogenic Gene Regulatory Network Jason Bazil 1/18/13 Cardiac Physiome Workshop 213 Reverse Engineering Gene Regulatory Networks Two main questions need addressed: 1) What s connected
More information